Corradini Paolo

PROFESSORE ORDINARIO
SSD
MED/15 - MALATTIE DEL SANGUE
Settore concorsuale
06/D3 - MALATTIE DEL SANGUE, ONCOLOGIA E REUMATOLOGIA

Contatti

Sede di lavoro

Via Venezian, 1
20133 MILANO (MI)

Altri numeri di telefono
02 23902343
E-mail di ateneo
Ricevimento
previo appuntamento da concordare via e-mail

Didattica

Ricerca

Pubblicazioni
  • Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk / K. Weisel, A. Spencer, S. Lentzsch, H. Avet-Loiseau, T.M. Mark, I. Spicka, T. Masszi, B. Lauri, M.D. Levin, A. Bosi, V. Hungria, M. Cavo, J.J. Lee, A. Nooka, H. Quach, M. Munder, C. Lee, W. Barreto, P. Corradini, C.K. Min, A.A. Chanan-Khan, N. Horvath, M. Capra, M. Beksac, R. Ovilla, J.C. Jo, H.J. Shin, P. Sonneveld, T. Casneuf, N. DeAngelis, H. Amin, J. Ukropec, R. Kobos, M.V. Mateos. - In: JOURNAL OF HEMATOLOGY & ONCOLOGY. - ISSN 1756-8722. - 13:1(2020 Aug 20), pp. 115.1-115.11.
  • High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG) / S. Salmoiraghi, R. Cavagna, P. Zanghi', C. Pavoni, A. Michelato, K. Buklijas, L. Elidi, T. Intermesoli, F. Lussana, E. Oldani, C. Caprioli, P. Stefanoni, G. Gianfaldoni, E. Audisio, E. Terruzzi, L. De Paoli, E. Borlenghi, I. Cavattoni, D. Mattei, A. Scattolin, M. Tajana, F. Ciceri, E. Todisco, L. Campiotti, P. Corradini, N. Fracchiolla, R. Bassan, A. Rambaldi, O. Spinelli. - In: CANCERS. - ISSN 2072-6694. - 12:8(2020 Aug 11), pp. 2242.1-2242.14.
  • Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase / C. Oltolini, A. Guidetti, M. Ripa, B. Castiglioni, C. Tassan Din, S. Mastaglio, D. Canetti, G. Monti, A. Andolina, C. Molinari, A. Poloniato, A. Mastrangelo, M. Ferrante, M. Lanzillotta, P. Scarpellini, A. Castagna, P. Corradini, F. Ciceri. - In: HEMASPHERE. - ISSN 2572-9241. - 4:4(2020 Aug), pp. e448.1-e448.4.
  • Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma : Three-year Follow-up of CASTOR / M.-. Mateos, P. Sonneveld, V. Hungria, A.K. Nooka, J.A. Estell, W. Barreto, P. Corradini, C.-. Min, E. Medvedova, K. Weisel, C. Chiu, J.M. Schecter, H. Amin, X. Qin, J. Ukropec, R. Kobos, A. Spencer. - In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. - ISSN 2152-2650. - 20:8(2020 Aug), pp. 509-518.
  • PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study / C. Brunelli, C. Borreani, A. Caraceni, A. Roli, M. Bellazzi, L. Lombi, E. Zito, C. Pellegrini, P. Spada, S. Kaasa, A.M. Foschi, G. Apolone, M. Bellazzi, F. Belli, C. Borreani, C. Brunelli, G. Capri, A. Caraceni, P. Casali, P. Corradini, F. De Braud, A.M. Foschi, S. Folli, M. Garassino, L. Licitra, N. Nicolai, C. Pellegrini, M. Platania, G. Procopio. - In: HEALTH AND QUALITY OF LIFE OUTCOMES. - ISSN 1477-7525. - 18:1(2020 Jul 28).